These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 4577118)

  • 1. Role of dopamine in the nervous system.
    Barbeau A
    Monogr Hum Genet; 1972; 6():114-36. PubMed ID: 4577118
    [No Abstract]   [Full Text] [Related]  

  • 2. Dopamine is an important neurotransmitter in the autonomic nervous system.
    Thorner MO
    Lancet; 1975 Mar; 1(7908):662-5. PubMed ID: 47084
    [No Abstract]   [Full Text] [Related]  

  • 3. Neurohumoral interactions and basal ganglia function and dysfunction.
    Hornykiewicz O
    Res Publ Assoc Res Nerv Ment Dis; 1976; 55():269-80. PubMed ID: 12547
    [No Abstract]   [Full Text] [Related]  

  • 4. L-dopa in Parkinsonism. A possible mechanism of action.
    Ng LK; Chase TN; Colburn RW; Kopin IJ
    Neurology; 1972 Jul; 22(7):688-96. PubMed ID: 4673250
    [No Abstract]   [Full Text] [Related]  

  • 5. The biochemistry of the basal ganglia and Parkinson's disease.
    Curzon G
    Postgrad Med J; 1977 Dec; 53(626):719-25. PubMed ID: 24209
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The clinical physiology of side effects in long-term L-DOPA therapy.
    Barbeau A
    Adv Neurol; 1974; 5():347-365. PubMed ID: 4155234
    [No Abstract]   [Full Text] [Related]  

  • 7. L-Dopa and Parkinsonism.
    Calne DB; Sandler M
    Nature; 1970 Apr; 226(5240):21-4. PubMed ID: 4907560
    [No Abstract]   [Full Text] [Related]  

  • 8. The pharmacology of parkinsonism (a review).
    Klawans HL
    Dis Nerv Syst; 1968 Dec; 29(12):805-16. PubMed ID: 4388368
    [No Abstract]   [Full Text] [Related]  

  • 9. Cerebral catecholamines after levodopa therapy.
    Greer M; Collins GH; Anton AH
    Arch Neurol; 1971 Nov; 25(5):461-7. PubMed ID: 5110888
    [No Abstract]   [Full Text] [Related]  

  • 10. [The therapeutic effect of L-dopa].
    Groneberg P; Struppler A
    Naturwissenschaften; 1972 Nov; 59(11):492-6. PubMed ID: 4657650
    [No Abstract]   [Full Text] [Related]  

  • 11. The balance of biogenic amines as condition for normal behaviour.
    Birkmayer W; Danielczyk W; Neumayer E; Riederer P
    J Neural Transm; 1972; 33(2):163-78. PubMed ID: 4643007
    [No Abstract]   [Full Text] [Related]  

  • 12. [Treatment of Parkinson's disease with L-dopa].
    Guglielmi L; Vecchi L
    Clin Ter; 1970 May; 53(3):259-69. PubMed ID: 4917328
    [No Abstract]   [Full Text] [Related]  

  • 13. Brain catecholamines and their metabolites in Parkinsonian patients. Treatment with levodopa alone or combined with a decarboxylase inhibitor.
    Rinne UK; Sonninen V
    Arch Neurol; 1973 Feb; 28(2):107-10. PubMed ID: 4683147
    [No Abstract]   [Full Text] [Related]  

  • 14. Presynaptic modulation of neurochemical transmission.
    Vizi ES
    Prog Neurobiol; 1979; 12(3-4):181-290. PubMed ID: 39316
    [No Abstract]   [Full Text] [Related]  

  • 15. The probenecid test in Parkinson's disease.
    Lakke JP; Korf J; Hoorntje S; Schut T; van Praag HM
    Psychiatr Neurol Neurochir; 1973; 76(2):139-46. PubMed ID: 4700931
    [No Abstract]   [Full Text] [Related]  

  • 16. Drug-induced changes in brain dopamine and their relation to parkinsonism.
    Vogt M
    Sci Basis Med Annu Rev; 1970; ():276-91. PubMed ID: 4319923
    [No Abstract]   [Full Text] [Related]  

  • 17. Possible sites of action of monoamines in hypothalamohypophyseal function.
    Wurtman RJ
    Neurosci Res Program Bull; 1971 Mar; 9(2):214-7. PubMed ID: 4368023
    [No Abstract]   [Full Text] [Related]  

  • 18. The role of biochemical and neurohumoral factors in the laboratory evaluation of antiepileptic drugs.
    Maynert EW
    Epilepsia; 1969 Jun; 10(2):145-62. PubMed ID: 4308258
    [No Abstract]   [Full Text] [Related]  

  • 19. Effects of 6-hydroxydopamine on catecholamine containing neurones in the rat brain.
    Uretsky NJ; Iversen LL
    J Neurochem; 1970 Feb; 17(2):269-78. PubMed ID: 5494056
    [No Abstract]   [Full Text] [Related]  

  • 20. Striatonigral degeneration. Response to levodopa therapy with pathological and neurochemical correlation.
    Sharpe JA; Rewcastle NB; Lloyd KG; Hornykiewicz O; Hill M; Tasker RR
    J Neurol Sci; 1973 Jul; 19(3):275-86. PubMed ID: 4716845
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.